Form 8-K - Current report:
SEC Accession No. 0001193125-24-283685
Filing Date
2024-12-23
Accepted
2024-12-23 08:01:00
Documents
16
Period of Report
2024-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d893536d8k.htm   iXBRL 8-K 45799
2 EX-2.1 d893536dex21.htm EX-2.1 37099
3 EX-10.1 d893536dex101.htm EX-10.1 84410
  Complete submission text file 0001193125-24-283685.txt   382929

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA blacu-20241217.xsd EX-101.SCH 4879
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20241217_def.xml EX-101.DEF 15323
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20241217_lab.xml EX-101.LAB 26121
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20241217_pre.xml EX-101.PRE 16487
18 EXTRACTED XBRL INSTANCE DOCUMENT d893536d8k_htm.xml XML 9114
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 241569912
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)